BioLife Sciences, Inc. (OTC:PK BLFE) (BioLife or the Company) Is Pleased to Announce the Release of the Prototype of the Company's Copper-Infused Microfiber Towels for Q2 of the Fiscal Year
HENDERSON, NV, Feb. 23, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – The Copper-Infused Microfiber Towels are copper-variations of traditional microfiber towels, designed to outlast competitors' standard microfiber
BioLife Sciences Inc. (OTC: BLFE) Announces Letter of Intent for Exclusive Licensing Deal With Canadian Firm
HENDERSON, NV, Feb. 02, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences (OTCPK: BLFE) is pleased to announce that it has entered into a non-binding letter of intent ("LOI") dated Febru
BioLife Sciences Inc. Seeks to Retain an Auditing and Consulting Services Firm
HENDERSON, NV, Nov. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences Inc. ("BioLife" or the "Company") (OTCPK: BLFE) announced that it is seeking to retain an auditing and consulting
BioLife Sciences Inc. (OTC: BLFE) Enters Into Negotiations for Exclusive Licensing Deal With Canadian Firm
HENDERSON, NV, Sept. 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences (OTCPK: BLFE) is pleased to announce that it has entered into negotiations with Canadian Firm--Work In Motion to
BioLife Sciences Announces Launch of Hemp-Based Product Line
HENDERSON, Nev., Aug. 17, 2022 (GLOBE NEWSWIRE) -- BioLife Sciences Inc. ("BioLife" or the "Company") (OTC: BLFE) announced today the launch of its first line of cannabinoid consumer products. The C
BioLife Sciences Retains Benzinga for Marketing Campaign
HENDERSON, Nev., Aug. 09, 2022 (GLOBE NEWSWIRE) -- BioLife Sciences Inc. (OTCPK: BLFE) (the "Company" or BioLife), announced today that it has retained Benzinga to launch marketing and advertising s
BioLife Sciences Retains GS Whitney & Co for Corporate Relations
HENDERSON, NV, Aug. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences Inc. (OTCPK: BLFE) (the "Company" or BioLife) announced today it has engaged GS Whitney & Co. (GS Whitney) to assist in building brand awareness, providing communic
BioLife Sciences Inc. COO Details Innovation and Market Strategies in Audio Interview with SmallCapVoice.com
AUSTIN, Texas, Aug. 02, 2022 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. ("SCV") announces the availability of a new interview with Nika Jaksic, COO of BioLife Sciences Inc. (OTCPK: BLFE) (the "Company"), to provide an overview of the Company's operatio
BioLife Sciences Retains SmallCapVoice.com for Corporate Relations Advisory Services
HENDERSON, NV, July 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences Inc. (OTCPK: BLFE) (the "Company" or BioLife), announced today that it has retained SmallCapVoice.com Inc. ("SCV
BioLife Sciences Inc. Announces SEC Qualification of Regulation A+ Tier 1 Offering
HENDERSON, NV, July 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences Inc. (OTC: BLFE) today announced it has successfully received qualification of its offering statement on Form 1-A
BioLife Sciences Inc. Files Form 1-A with the Securities and Exchange Commission (SEC) to Raise Capital Under a Tier I Regulation A+ Offering
HENDERSON, NV, June 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences Inc. (OTC: BLFE) (the "Company" or "BioLife"), announced today that it has filed Form 1-A with the Securities and
BioLife Sciences Inc. To Incorporate New Sub-Sector Dedicated To CBD
BioLife Sciences (OTCPK: BLFE), a firm dedicated to developing, licensing, and distributing antimicrobial products and disruptive technologies, announced on Tuesday that it is expanding its recently a
BioLife Sciences Inc. (OTC: Markets: BLFE) Announced Today It Will Be Expanding Its Newly Formed Orthomolecular Medicine and Natural Health Products Department With a Subsector Dedicated to Cannabidiol (CBD) Sales and Products
HENDERSON, NV, March 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences (OTCPK: BLFE) (the "Company" or "BioLife) is pleased to announce that it is expanding its recently announced ort
BioLife Sciences Inc. (OTC Markets: BLFE) Announced Today That the Company is Launching a New Life Sciences Division
Henderson, NV, Feb. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences (OTCPK: BLFE) is pleased to announce the launching of a new life sciences division, aimed at honing in on disrup
BioLife Sciences Inc. (OTC Markets: BLFE) Announced Today That the Company Has Finalized a Definitive Agreement With Health Box LLC for the 100% Acquisition of the Orthomolecular Medicine and Natural Health Products Company
Henderson, Nevada, Feb. 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences (OTCPK: BLFE) is pleased to announce that it has finalized a definitive agreement (the "Agreement") with Hea
BioLife Sciences Inc. (OTC Markets: BLFE) Signs LOI with Health Box LLC Towards the 100% Acquisition of the Arizona, USA Based Entity Specializing in Advanced Orthomolecular Medicine and Natural Health Products Development and Research
Toronto, Ontario, Canada, Jan. 25, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences (OTCPK : BLFE) is pleased to announce that it has entered into exclusive negotiations with Health Box
The latest trend of Wall Street predators: Goldman Sachs Group bought Alibaba Group Holding Ltd Soros to clear Tencent Music.
The trend of the investment predators on Wall Street has always been concerned by the market, and the change in the position of the investment predators may become a new weather vane for the market. Recently, the positions of these investment giants in the second quarter were announced. Soros's family office continued to bet on technology stocks in the second quarter after the Soros fund continued to bet on technology stocks against the market in the first quarter. According to overseas media reports, according to the 13F report submitted to the regulator by Soros Fund Management, Soros's family office, Soros Fund Management did more than 24 stocks in the second quarter, including three leading technology stocks such as Amazon.Com Inc; a total of 14 stocks were cleared, reducing their holdings.
Japanese bank Mizuho joins Wall Street salary increase to $100,000 for junior bankers
People familiar with the matter revealed that Mizuho Financial Group joined Wall Street's salary increase team to raise the salaries of its junior bankers in the US. A source familiar with the matter, who did not wish to be named, revealed that Mizuho Americas, a subsidiary of the Japanese bank, raised the annual salary of a junior analyst in the first year of employment to 100,000 US dollars. As work intensity increases and competition for talent intensifies, in recent weeks, J.P. Morgan, Citibank, Deutsche Bank, Barclays, and Lazard Ltd. have raised the salary of analysts in their first year of employment to $100,000. Providing courses and training for some of the largest investment banks
The break-even inflation rate shows that the market gradually agrees with the Fed's point of view.
Not only is the market beginning to accept that the rise in inflation is temporary, but expectations for peak inflation have also fallen. From this point of view, it is not surprising that Treasury yields have fallen. The gradual decline in break-even inflation and the widening gap between two-year and five-year indicators means that the Fed has not begun to explore the urgent need for downsized stimulus. It is not even clear that the market expects inflation to be higher than the Fed's target. Break-even inflation is not an accurate tool, it depends on two markets with different liquidity. It includes inflation expectations, but it also includes inflation risk premiums. The risk premium is difficult to calculate.
The weak demand for inflation-protected bonds shows that the market believes in the Fed's temporary inflation theory.
Demand for (TIPS), a 10-year inflation-protected bond issued by the US Treasury on Thursday, was weaker than expected, showing confidence in the Fed's claims of a temporary rise in inflation. The winning yield of the $13 billion TIPS bond was-0.805 per cent, about 2 basis points higher than the pre-issue yield, meaning demand was lower than brokers expected. The interest paid on the bond is determined by the consumer price index (CPI), and the difference between the TIPS yield and the yield of the ordinary 10-year bond before the issue is 2.46%, reflecting the average CPI increase needed to equalize the two. After this bond issue, the profit
No Data